Table 4. Endoscopic severity and clinical factors for candida esophagitis (n = 62).
| Factor | Mild (n = 33) | Severe (n = 29) | P |
| Agea | 46 (33, 67) | 41 (28, 59) | 0.18c |
| Sex (male) | 30 (90.9%) | 25 (86.2%) | 0.56 |
| Sexual behavior (MSM) | 21 (63.6%) | 18 (62.1%) | 1.00d |
| CD4+ cell count (cells/μL)a | 80 (12, 425) | 27 (9, 226) | 0.04d |
| HIV-RNA viral load (copies/mL) a | 3.8×104 (<40, 6.5×105) | 6.3×104 (<40, 2.2×105) | 0.90c |
| History of HAART | 16 (48.5%) | 16 (55.2%) | 0.60d |
| With GI symptoms | 14 (42.4%) | 13 (44.8%) | 0.85d |
| With oral candidiasisb | 7/20 (35%) | 10/18 (55.6%) | 0.38d |
a
Median (interquartile range).
b
The existence of oral candidiasis was checked in 38 patients by endoscopy.
c
P for Mann-Whitney U test; d P for Fisher's exact probability test.
Abbreviations: MSM, men who have sex with men; HAART, highly active antiretroviral therapy.